Post by Myriad Genetics

Today we announced newly published data from the largest individual-patient-data meta-analysis of Prolaris to date, showing the Prolaris Biopsy Test adds significant prognostic information beyond conventional clinical risk categories for patients with localized prostate cancer. Read more: https://lnkd.in/eTD9iDJi